Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 103 for “"ADPKD"”.
-
Chirurgische Therapie der Autosomalen-Dominanten Polyzystischen Nierenerkrankung (ADPKD)
… dominante polyzystische Nierenerkrankung (ADPKD) weltweit rund 12,5 Millionen Menschen. Charak-teristisch für die ADPKD sind multiple Nierenzysten, die das gesunde Nierenparenchym verdrängen. Zystennieren können ein Gewicht von mehreren Kilogramm erreichen. Die enorme Größe und abnorme …
-
VCP Inhibition as a Targeted Therapy for Autosomal Dominant Polycystic Kidney Disease (ADPKD): Unveiling the Role of VCP as a Ciliary Protein in ADPKD
Autosomal dominant polycystic kidney disease (ADPKD) is a hereditary disorder characterized by progressive renal cyst development, leading to kidney enlargement and renal failure. The causative genes of ADPKD, Pkd1 and Pkd2, encode for the ciliary protein PC1 and PC2, positioning ADPKD in the …
-
The role of sphingolipids in autosomal dominant polycystic kidney disease (ADPKD)
Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder characterized by the development of renal cysts and eventual renal failure. There is currently no cure for ADPKD, but various treatments are available to alleviate the symptoms. In ADPKD, cystic renal epithelia are prevalent …
-
Reliable volume measurements in ADPKD patients: a study of MRI sequences
… Autosomal dominant polycystic kidney disease (ADPKD) is characterized by gradual kidney enlargement and cyst growth prior to loss of kidney function. The Consortium for Radiologic Imaging Studies in Polycystic Kidney Disease (CRISP) created a standard magnetic resonance imaging (MRI) protocol …
-
Navigating Gaps in ADPKD Research: Early Risk Modeling, Real-World Treatment, and Patient Partnerships
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common inherited kidney disorder and a leading cause of renal failure. While significant progress has been made in understanding ADPKD progression and treatment, gaps remain in early prognostic modeling, treatment implementation, and …
-
Reduktion der Viabilität von Zystenepithelzellen durch die Hemmung der Ire1α Endoribonukleaseaktivität als neuer Therapieansatz bei ADPKD
… dominante polyzystische Nierenerkrankung (ADPKD), verursacht durch Mutationen im Pkd1 und Pkd2 Gen, zeigt ein langsam progressives Wachstum von bilateralen Nierenzysten und führt mit Verdrängung von gesundem Nierengewebe zum terminalen Nierenversagen. Die Zysteninitiierung beginnt mit einer …
-
TRPM3 modulation and cyst reversibility in ex vivo and organoid models of autosomal dominant polycystic kidney disease (ADPKD)
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease, affecting approximately 1 in 1000 live births. It is characterised by multiple fluid-filled cysts in renal tubules. ADPKD is associated with mutations in the PKD1 and PKD2 genes, which encode the …
-
Health Care Resource Utilization and Expenditures in Persons with Autosomal Dominant Polycystic Kidney Disease
… of autosomal dominant polycystic kidney disease (ADPKD), to determine all-cause health care resource utilization and all-cause health care expenditures, to determine incremental health care resource utilization, and to determine incremental health care expenditures associated with ADPKD. An …
-
Novel effects of ouabain in autosomal dominant polycystic kidney disease cystogenesis
Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in Pkd1 or Pkd2, genes encoding for polycystin-1 (PC-1) and polycystin-2 (PC-2), respectively. ADPKD is characterized by the progressive growth of numerous fluid-filled renal cysts. Cyst formation and growth depends on …
-
Na,K-ATPase signaling in cyst progression in autosomal dominant polycystic kidney disease
Autosomal dominant polycystic kidney disease (ADPKD) is the most common monogenetic disorder of the kidney, affecting 1:500-1000 live births across the world. It is characterized by the formation and growth of fluid-filled cysts which grow larger throughout the lifetime of the patient, eventually …
-
Contributions of Ouabain to the Autosomal Dominant Polycystic Kidney Disease Phenotype
Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder, caused by mutations in either of the PKD1 or PKD2 genes, which leads to the development and growth of multiple fluid-filled cysts in the kidney. The cysts are present at birth and grow throughout the lifetime of the …
-
Growth hormone inhibition in Autosomal Dominant Polycystic Kidney Disease
… Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common hereditary renal disease worldwide and the primary genetic cause of end stage- renal failure. ADPKD is characterised by progressive renal hypertrophy and development of renal cysts, leading to loss of function and renal …
-
NEAR-INFRARED HEMICYANINE AND BODIPY SENSORS FOR MONITORING MITOCHONDRIAL VISCOSITY IN LIVE CANCER CELLS, DROSOPHILA MELANOGASTER LARVAE, AND ADPKD KIDNEY TISSUE
… in Drosophila melanogaster larvae as well as in ADPKD affected mice kidney tissue. In all of these scenarios, the fluorescent intensity increased with viscosity. Sensor A has provided significant evidence that it would be a useful tool in monitoring mitochondrial viscosity in a variety of …
-
Metabolic Insights into Cyst Fluid Composition and the Role of Taurine in Polycystic Kidney Disease
… in two major forms, autosomal dominant PKD (ADPKD), and autosomal recessive PKD (ARPKD). ADPKD is typically adult-onset and caused by mutations in the PKD1 and PKD2 genes, and ARPKD generally manifests in utero and is caused by mutations in the PKHD1 gene. Despite the severity of the disease, …
-
TRANSMEMBRANE PROTEIN 2: A NOVEL PROTEIN IN POLYCYSTIC KIDNEY DISEASE
… Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a common hereditary cause of end stage renal disease. Affected individuals have mutations in PKD1 or PKD2 genes, generating defective polycystin -1 (PC1) or polycystin -2 (PC2) protein, respectively. Transmembrane protein 2 (TMEM2) is a …
Page 1 of 6